Engineering Biospecificity into a Single Albumin-Binding Domain
Monoclonal antibodies have been widely used in nearly all areas of life science for over three decades and represent a growing class of agents also in the clinics, mainly due to their generally high specificity and excellent pharmacokinetic properties. Today, regulatory authorities have approved over 20 monoclonal antibodies for therapeutic or diagnostic use.